Therapy Areas: Oncology
IHI and Bristol Myers Squibb launch initiative to expand cancer clinical trial access
22 October 2026 - The Institute for Healthcare Improvement (IHI) and biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) on Thursday launched a three-year Cancer Collective Action Collaborative ...
Summit Therapeutics and ECOG-ACRIN launch Phase II/III trial collaboration for biliary tract cancer
21 October 2026 - Biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ:SMMT) said on Wednesday that it has partnered with the ECOG-ACRIN Cancer Research Group to evaluate ivonescimab in ...
Abbott secures CE Mark for Cologuard Plus in Europe
20 October 2026 - Abbott Laboratories (NYSE: ABT), a global healthcare company, said on Tuesday that Cologuard Plus has received CE Mark approval under the European Union's In Vitro Diagnostic Me...
Oracle partners AstraZeneca for AI-enabled healthcare innovation
20 October 2026 - US-based tech firm Oracle Corporation (NYSE: ORCL) announced on Tuesday an agreement with UK-based pharmaceutical company AstraZeneca (LON: AZN) to explore how AI and real-world data...
Telix and Ekalia to develop US astatine-211 production
...
GSK reports 61% response rate for investigational lung cancer drug
19 October 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) on Monday reported a confirmed overall response rate of 61% for its investigational antibody-drug conjugate risvutatug rezete...